Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2009 2
2011 3
2012 4
2013 9
2014 3
2015 6
2016 8
2017 4
2018 5
2019 10
2020 12
2021 6
2022 9
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
PAI-1 is a vascular cell-specific HIF-2-dependent angiogenic factor that promotes retinal neovascularization in diabetic patients.
Qin Y, Zhang J, Babapoor-Farrokhran S, Applewhite B, Deshpande M, Megarity H, Flores-Bellver M, Aparicio-Domingo S, Ma T, Rui Y, Tzeng SY, Green JJ, Canto-Soler MV, Montaner S, Sodhi A. Qin Y, et al. Among authors: tzeng sy. Sci Adv. 2022 Mar 4;8(9):eabm1896. doi: 10.1126/sciadv.abm1896. Epub 2022 Mar 2. Sci Adv. 2022. PMID: 35235351 Free PMC article.
HIF-1α and HIF-2α redundantly promote retinal neovascularization in patients with ischemic retinal disease.
Zhang J, Qin Y, Martinez M, Flores-Bellver M, Rodrigues M, Dinabandhu A, Cao X, Deshpande M, Qin Y, Aparicio-Domingo S, Rui Y, Tzeng SY, Salman S, Yuan J, Scott AW, Green JJ, Canto-Soler MV, Semenza GL, Montaner S, Sodhi A. Zhang J, et al. Among authors: tzeng sy. J Clin Invest. 2021 Jun 15;131(12):e139202. doi: 10.1172/JCI139202. J Clin Invest. 2021. PMID: 34128478 Free PMC article.
ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization.
Qin Y, Dinabandhu A, Cao X, Sanchez JC, Jee K, Rodrigues M, Guo C, Zhang J, Vancel J, Menon D, Khan NS, Ma T, Tzeng SY, Daoud Y, Green JJ, Semenza GL, Montaner S, Sodhi A. Qin Y, et al. Among authors: tzeng sy. JCI Insight. 2022 Jul 8;7(13):e157896. doi: 10.1172/jci.insight.157896. JCI Insight. 2022. PMID: 35653189 Free PMC article.
Gene delivery for immunoengineering.
Neshat SY, Tzeng SY, Green JJ. Neshat SY, et al. Among authors: tzeng sy. Curr Opin Biotechnol. 2020 Dec;66:1-10. doi: 10.1016/j.copbio.2020.05.008. Epub 2020 Jun 15. Curr Opin Biotechnol. 2020. PMID: 32554325 Free PMC article. Review.
Bioengineered nanoparticles for siRNA delivery.
Kozielski KL, Tzeng SY, Green JJ. Kozielski KL, et al. Among authors: tzeng sy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Sep-Oct;5(5):449-68. doi: 10.1002/wnan.1233. Epub 2013 Jul 2. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013. PMID: 23821336 Free PMC article. Review.
siRNA nanomedicine: the promise of bioreducible materials.
Kozielski KL, Tzeng SY, Green JJ. Kozielski KL, et al. Among authors: tzeng sy. Expert Rev Med Devices. 2013 Jan;10(1):7-10. doi: 10.1586/erd.12.73. Expert Rev Med Devices. 2013. PMID: 23278217 No abstract available.
Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity.
Zhu Y, Ma J, Shen R, Lin J, Li S, Lu X, Stelzel JL, Kong J, Cheng L, Vuong I, Yao ZC, Wei C, Korinetz NM, Toh WH, Choy J, Reynolds RA, Shears MJ, Cho WJ, Livingston NK, Howard GP, Hu Y, Tzeng SY, Zack DJ, Green JJ, Zheng L, Doloff JC, Schneck JP, Reddy SK, Murphy SC, Mao HQ. Zhu Y, et al. Among authors: tzeng sy. Nat Biomed Eng. 2023 Dec 11. doi: 10.1038/s41551-023-01131-0. Online ahead of print. Nat Biomed Eng. 2023. PMID: 38082180
91 results